Amarin Corp Plc (AMRN)

[ziploc_1]

I think it would now be worthwhile for Amarin to discuss with the FDA whether the studies by Mochida on MD2119 in Japan would sufficient for approval in the U.S....or whether additional studies would be required.


If the FDA indicates that more lab studies are necessary, Amarin could complete those with the help of Dr. Bhatt or Dr. Mason in a timely fashion.